miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia

Rosa Visone, Angelo Veronese, Laura Z. Rassenti, Veronica Balatti, Dennis K. Pearl, Mario Acunzo, Stefano Volinia, Cristian Taccioli, Thomas J. Kipps, Carlo M. Croce

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Fingerprint

Dive into the research topics of 'miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds